IRMD - CIK 0001325618
IRADIMED CORP trades as IRMD and has a market capitalization of $1.24 B, making it the #2481 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $83.81M, up 14.4% from the prior year and net income of $22.48M. This page tracks IRADIMED CORP through 760 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years IRADIMED CORP's revenue grew from $32.50M to $83.81M, a compound annual growth rate of 11.1%. Net profit margin expanded from 22.2% to 26.8% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-20 |
| SCHEDULE 13G/A | - | 2026-05-14 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-06 |
| Quarterly report | 10-Q | 2026-05-01 |
| Major company event | 8-K | 2026-05-01 |
| Annual report to shareholders | ARS | 2026-04-30 |
| Proxy statement | DEF 14A | 2026-04-30 |
The largest companies sharing IRADIMED CORP's SEC industry classification (surgical & medical instruments & apparatus).
IRADIMED CORP (IRMD) has a market capitalization of $1.24 B as of 2026-06-10, ranking #2481 among US-listed companies.
IRADIMED CORP reported revenue of $83.81M for fiscal year 2025, an increase of 14.4% year over year.
Yes. IRADIMED CORP reported net income of $22.48M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.